Aignosis: Empowering Early Detection

Aignosis is an AI-assisted autism and developmental screening tool that catches developmental concerns years before most children get a diagnosis, and connects families to what comes next.

Aignosis eye-tracking screening running in a classroom full of children

Screening that goes to the child in classrooms, clinics and community camps across India.

Our Story

Different doors. Same reason for walking through them.

No child should be missed just because the system wasn't built to catch them in time. That's why Aignosis exists.

Raksheet Jain

Raksheet Jain

Co-Founder

Raksheet's story

I grew up inside my father's medical practice in Jaipur, close enough to watch it from the inside. What stayed with me wasn't the illnesses themselves but the timing: parents describing a child who wasn't quite meeting a milestone, less eye contact than expected, a word that hadn't come yet, and being told, gently, to wait and watch. By the time anyone acted, the child was often four or five, well past the window when early support tends to matter most.

I watched that pattern repeat, consultation after consultation, until it stopped being something I noticed and became something I couldn't stop thinking about.

I had an offer from Kellogg's. A stable, well-worn path. I turned it down anyway, because I'd already seen what the cost of waiting looks like on a family.

Divyansh Mangal

Divyansh Mangal

Co-Founder

Divyansh's story

I'm a physicist who fell for artificial intelligence. I was standing at the entrance to a PhD, the kind of opportunity most researchers spend years working toward, when I chose to walk through a different door instead.

I staked my training on a harder, messier question: could a laptop webcam notice, in a few minutes, what an overstretched healthcare system was taking years to catch?

I refused to take shortcuts. Our models don't just glance at a child's gaze, they read it as a signal unfolding moment by moment. I tested that against simpler methods, again and again, until I trusted it actually worked.

For me, it wasn't about testing a model. It was about trying to give a child back the years “wait and watch” was costing them.

Featured, WTF is... Podcast by Nikhil Kamath

Raksheet and Divyansh join Nikhil Kamath to talk through Aignosis and early autism screening.

Our Goal

We want a sign to never go unnoticed because no one knew to look for it. Our goal is to close the distance between a parent's first worry and the help that's already out there. Parents, doctors, schools, and therapists, working as one circle around the child instead of in separate rooms. No child's future should be decided by how long it took someone to notice. These are the children who will grow into everything that comes next, and what we build for them now is what we're building for all of us, later.

A young child taking an Aignosis screening test on a laptop
A short, non-invasive screening with no needles, no long waiting lists.
A child being screened at an Aignosis-enabled clinic workstation

Our Vision

To create a world where every child has the opportunity to thrive through early detection and personalized developmental support, breaking barriers to accessibility and affordability in autism screening.

Children and teachers at a school screening camp run with Aignosis

Our Mission

To revolutionize early autism detection by leveraging AI and cutting-edge technology to deliver accurate, affordable, and non-invasive screening solutions. We aim to empower families, educators, and clinicians with actionable insights, fostering early intervention.

The Aignosis team with children at a community screening drive

Our Purpose

To bridge the gap between late diagnosis and timely intervention, ensuring that every child's unique potential is recognized and nurtured. By making autism screening accessible to all, we strive to transform lives, enhance developmental outcomes, and contribute to a more inclusive society.

Our Project Team

The Minds Behind Aignosis

At Aignosis, we are driven by the vision to revolutionize early detection of neurodevelopmental disorders through cutting-edge AI technology. Our passionate and diverse team brings together expertise in healthcare, artificial intelligence, and entrepreneurship to make autism screening accessible, affordable, and scalable for every child.

An Aignosis co-founder at the AI Impact Summit
AI Impact Summit
Aignosis co-founders at a table during an event session
The team, off-stage
Clinical Guidance

Advisory Board

Dr. Rajesh Jain

Dr. Rajesh Jain

Director & Consultant Pediatrician, Raksheet Hospital, Jaipur

Dr. Rajesh Jain is a renowned paediatrician and the Director at Raksheet Hospital, Jaipur. With extensive experience in pediatric care and developmental health, Dr. Jain has been a vital contributor to Aignosis's clinical approach.

Dr. Dhananjay Mangal

Dr. Dhananjay Mangal

Director & Consultant Pediatrician, Babylon Hospital, Jaipur

Dr. Dhananjay Mangal brings over 27 years of pediatric healthcare experience and currently serves as the President of the Rajasthan Chapter of the Telemedicine Society of India.

Backed By

Strategic Investors & Mentors

Mr. Amit Jain

Mr. Amit Jain

Strategic Mentor & Investor

Amit Jain, an alumnus of IIT Delhi, is the Co-Founder and CEO of CarDekho Group, a prominent Autotech company in India that has achieved unicorn status with a valuation of $1.2 billion in 2021.

Mr. Rajneesh Bhandari

Mr. Rajneesh Bhandari

Founder, NeuroEquilibrium Diagnostic Systems Pvt. Ltd.

Rajneesh Bhandari is a seasoned entrepreneur in healthcare diagnostics, having founded NeuroEquilibrium, India's leading vestibular diagnostic network, with 250+ centers nationwide.

Mr. Varun Dua

Mr. Varun Dua

Founder & CEO, Acko

Varun Dua is the Founder and CEO of Acko, a digital-first insurance company transforming India's insurance industry with technology-driven, customer-centric solutions. With a vision to simplify insurance, he has positioned Acko as a leading insurtech startup in India.

Mr. Nikhil Kamath

Mr. Nikhil Kamath

Co-Founder, Zerodha & True Beacon

Nikhil Kamath is the Co-Founder of Zerodha, India's largest stock brokerage firm, and True Beacon, an asset management company. A self-taught trader, he is known for revolutionizing India's investment landscape with commission-free trading and wealth management solutions.